Literature DB >> 26440882

Structural and Functional Evidence for Testosterone Activation of GPRC6A in Peripheral Tissues.

Min Pi1, Karan Kapoor1, Yunpeng Wu1, Ruisong Ye1, Susan E Senogles1, Satoru K Nishimoto1, Dong-Jin Hwang1, Duane D Miller1, Ramesh Narayanan1, Jeremy C Smith1, Jerome Baudry1, L Darryl Quarles1.   

Abstract

G protein-coupled receptor (GPCR) family C group 6 member A (GPRC6A) is a multiligand GPCR that is activated by cations, L-amino acids, and osteocalcin. GPRC6A plays an important role in the regulation of testosterone (T) production and energy metabolism in mice. T has rapid, transcription-independent (nongenomic) effects that are mediated by a putative GPCR. We previously found that T can activate GPRC6A in vitro, but the possibility that T is a ligand for GPRC6A remains controversial. Here, we demonstrate direct T binding to GPRC6A and construct computational structural models of GPRC6A that are used to identify potential binding poses of T. Mutations of the predicted binding site residues were experimentally found to block T activation of GPRC6A, in agreement with the modeling. Using Gpr6ca(-/-) mice, we confirmed that loss of GPRC6A resulted in loss of T rapid signaling responses and elucidated several biological functions regulated by GPRC6A-dependent T rapid signaling, including T stimulation of insulin secretion in pancreatic islets and enzyme expression involved in the biosynthesis of T in Leydig cells. Finally, we identified a stereo-specific effect of an R-isomer of a selective androgen receptor modulator that is predicted to bind to and shown to activate GPRC6A but not androgen receptor. Together, our data show that GPRC6A directly mediates the rapid signaling response to T and uncovers previously unrecognized endocrine networks.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26440882      PMCID: PMC4664231          DOI: 10.1210/me.2015-1161

Source DB:  PubMed          Journal:  Mol Endocrinol        ISSN: 0888-8809


  66 in total

1.  Effects of a novel selective androgen receptor modulator on dexamethasone-induced and hypogonadism-induced muscle atrophy.

Authors:  Amanda Jones; Dong-Jin Hwang; Ramesh Narayanan; Duane D Miller; James T Dalton
Journal:  Endocrinology       Date:  2010-06-09       Impact factor: 4.736

Review 2.  Nonsteroidal selective androgen receptor modulators (SARMs): dissociating the anabolic and androgenic activities of the androgen receptor for therapeutic benefit.

Authors:  Michael L Mohler; Casey E Bohl; Amanda Jones; Christopher C Coss; Ramesh Narayanan; Yali He; Dong Jin Hwang; James T Dalton; Duane D Miller
Journal:  J Med Chem       Date:  2009-06-25       Impact factor: 7.446

3.  Effect of B-ring substitution pattern on binding mode of propionamide selective androgen receptor modulators.

Authors:  Casey E Bohl; Zengru Wu; Jiyun Chen; Michael L Mohler; Jun Yang; Dong Jin Hwang; Suni Mustafa; Duane D Miller; Charles E Bell; James T Dalton
Journal:  Bioorg Med Chem Lett       Date:  2008-09-05       Impact factor: 2.823

4.  Steroidal androgens and nonsteroidal, tissue-selective androgen receptor modulator, S-22, regulate androgen receptor function through distinct genomic and nongenomic signaling pathways.

Authors:  Ramesh Narayanan; Christopher C Coss; Muralimohan Yepuru; Jeffrey D Kearbey; Duane D Miller; James T Dalton
Journal:  Mol Endocrinol       Date:  2008-09-18

5.  Structure of a class C GPCR metabotropic glutamate receptor 1 bound to an allosteric modulator.

Authors:  Huixian Wu; Chong Wang; Karen J Gregory; Gye Won Han; Hyekyung P Cho; Yan Xia; Colleen M Niswender; Vsevolod Katritch; Jens Meiler; Vadim Cherezov; P Jeffrey Conn; Raymond C Stevens
Journal:  Science       Date:  2014-03-06       Impact factor: 47.728

Review 6.  Rapid signaling responses in Sertoli cell membranes induced by follicle stimulating hormone and testosterone: calcium inflow and electrophysiological changes.

Authors:  Eloísa S Loss; Ana Paula Jacobus; Guillermo F Wassermann
Journal:  Life Sci       Date:  2011-06-16       Impact factor: 5.037

7.  MAFFT multiple sequence alignment software version 7: improvements in performance and usability.

Authors:  Kazutaka Katoh; Daron M Standley
Journal:  Mol Biol Evol       Date:  2013-01-16       Impact factor: 16.240

8.  Inhibition of cyclin D1 expression by androgen receptor in breast cancer cells--identification of a novel androgen response element.

Authors:  Marilena Lanzino; Diego Sisci; Catia Morelli; Cecilia Garofalo; Stefania Catalano; Ivan Casaburi; Claudia Capparelli; Cinzia Giordano; Francesca Giordano; Marcello Maggiolini; Sebastiano Andò
Journal:  Nucleic Acids Res       Date:  2010-04-26       Impact factor: 16.971

Review 9.  The GPCR, class C, group 6, subtype A (GPRC6A) receptor: from cloning to physiological function.

Authors:  C Clemmensen; S Smajilovic; P Wellendorph; H Bräuner-Osborne
Journal:  Br J Pharmacol       Date:  2014-03       Impact factor: 8.739

10.  Testosterone protects against glucotoxicity-induced apoptosis of pancreatic β-cells (INS-1) and male mouse pancreatic islets.

Authors:  Wanthanee Hanchang; Namoiy Semprasert; Thawornchai Limjindaporn; Pa-thai Yenchitsomanus; Suwattanee Kooptiwut
Journal:  Endocrinology       Date:  2013-08-22       Impact factor: 4.736

View more
  22 in total

1.  Human GPRC6A Mediates Testosterone-Induced Mitogen-Activated Protein Kinases and mTORC1 Signaling in Prostate Cancer Cells.

Authors:  Ruisong Ye; Min Pi; Mohammed M Nooh; Suleiman W Bahout; L Darryl Quarles
Journal:  Mol Pharmacol       Date:  2019-03-20       Impact factor: 4.436

2.  Sex Hormones and Lung Inflammation.

Authors:  Jorge Reyes-García; Luis M Montaño; Abril Carbajal-García; Yong-Xiao Wang
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 3.  Nuclear receptors outside the nucleus: extranuclear signalling by steroid receptors.

Authors:  Ellis R Levin; Stephen R Hammes
Journal:  Nat Rev Mol Cell Biol       Date:  2016-10-12       Impact factor: 94.444

4.  Communication between genomic and non-genomic signaling events coordinate steroid hormone actions.

Authors:  Sandi R Wilkenfeld; Chenchu Lin; Daniel E Frigo
Journal:  Steroids       Date:  2017-11-16       Impact factor: 2.668

5.  Evidence for Osteocalcin Binding and Activation of GPRC6A in β-Cells.

Authors:  Min Pi; Karan Kapoor; Ruisong Ye; Satoru Kenneth Nishimoto; Jeremy C Smith; Jerome Baudry; Leigh Darryl Quarles
Journal:  Endocrinology       Date:  2016-03-23       Impact factor: 4.736

Review 6.  The carboxylation status of osteocalcin has important consequences for its structure and dynamics.

Authors:  Karan Kapoor; Min Pi; Satoru Kenneth Nishimoto; Leigh Darryl Quarles; Jerome Baudry; Jeremy C Smith
Journal:  Biochim Biophys Acta Gen Subj       Date:  2020-12-17       Impact factor: 3.770

Review 7.  Membrane-Initiated Estrogen, Androgen, and Progesterone Receptor Signaling in Health and Disease.

Authors:  Franck Mauvais-Jarvis; Carol A Lange; Ellis R Levin
Journal:  Endocr Rev       Date:  2022-07-13       Impact factor: 25.261

Review 8.  Genomic and non-genomic effects of androgens in the cardiovascular system: clinical implications.

Authors:  Angela K Lucas-Herald; Rheure Alves-Lopes; Augusto C Montezano; S Faisal Ahmed; Rhian M Touyz
Journal:  Clin Sci (Lond)       Date:  2017-07-01       Impact factor: 6.124

9.  CRISPR/Cas9 targeting of GPRC6A suppresses prostate cancer tumorigenesis in a human xenograft model.

Authors:  Ruisong Ye; Min Pi; John V Cox; Satoru K Nishimoto; L Darryl Quarles
Journal:  J Exp Clin Cancer Res       Date:  2017-06-28

10.  Functional characterization and anti-cancer action of the clinical phase II cardiac Na+/K+ ATPase inhibitor istaroxime: in vitro and in vivo properties and cross talk with the membrane androgen receptor.

Authors:  Konstantinos Alevizopoulos; Konstantinos Dimas; Natalia Papadopoulou; Eva-Maria Schmidt; Anna Tsapara; Saad Alkahtani; Sabina Honisch; Kyriakos C Prousis; Saud Alarifi; Theodora Calogeropoulou; Florian Lang; Christos Stournaras
Journal:  Oncotarget       Date:  2016-04-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.